Loading chat...
NY A06475
Bill
Status
3/5/2025
Primary Sponsor
Amanda Septimo
Click for details
AI Summary
-
Requires health insurance policies to fully cover comprehensive genetic testing and FDA-approved biomarker testing for ovarian and prostate cancers when recommended by a doctor, board-certified geneticist, or genetic counselor
-
Mandates coverage based on family or personal history, including after a patient's initial cancer diagnosis to help determine possible treatments
-
Extends genetic screening coverage to family members of prostate and ovarian cancer patients
-
Prohibits insurers from using genetic test results showing inherited mutations against family members for insurance coverage purposes
-
Eliminates all deductibles and coinsurance for this testing, requiring insurers to bear the full cost; takes effect 60 days after becoming law
Legislative Description
Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
Last Action
referred to insurance
1/7/2026